Key Takeaways & Executive Findings
- •• Histone acetylases, but not methyltransferases, are required for proper iron homeostasis in yeast under iron-deficient conditions. • Deletion of specific histone acetylase genes (GCN5, RTT109, SAS2, YNG2) does not affect growth under iron deficiency, but may influence transcriptional induction of iron-responsive genes. • The study highlights the epigenetic regulation of iron metabolism, expanding the understanding of how histone modifications contribute to cellular adaptation to iron stress. • These findings have implications for treating iron-related disorders and for biotechnological applications in yeast.
Abstract
Iron, an ancient and essential transition metal, is involved in various biological functions, including oxygen transport, DNA synthesis, heme production, and iron-sulfur clusters, which participate in electron transport, DNA repair, and other cellular processes. However, excessive iron can lead to oxidative stress, lipid peroxidation, and cell damage. Thus, maintaining the iron content within an appropriate safe range and maintaining the balance of iron metabolism play crucial roles in both cellular function and human health [1]. An important aspect of maintaining the balance of iron homeostasis is the regulation of the iron uptake system. In Saccharomyces cerevisiae, cells can either obtain iron from the external environment via the non-reducing siderophore transport system or transport iron from the extracellular space to the intracellular space via the reducing iron transport system [2]. Iron uptake system-related genes are regulated mainly by the transcription factor Aft1p. During iron deficiency, Aft1p translocates into the nucleus, binds to genes involved in iron metabolism, and regulates the expressions of genes involved in iron uptake systems [3]. In addition, when there is a problem in the synthesis of iron-sulfur clusters in the mitochondria, such as the lack of the iron chaperone Yfh1p, which promotes the synthesis of iron-sulfur clusters, the transcription and nuclear entry of the transcription factor Aft1p are also activated, thereby regulating the expressions of iron metabolism-related genes [4]. In addition to transcription factors, gene expression is also regulated by histones and their modifications at the epigenetic level. For example, histone H3K4 methylation is related to gene activation, H3K36 methylation plays an important role in the elongation of transcription, and histone acetylation results in the loss of nucleosome structure and facilitates gene expression [5]. Therefore, histone modifications should also play important roles in the regulation of iron homeostasis. The relationship between histone modifications and iron homeostasis has been reported in the literature. For example, the DNA methylation-binding protein MBD5 can change histone acetylation in the promoter region of the ferritin gene by recruiting the histone acetylase KAT2A protein [6]. Histone acetylation has also been reported to be reduced in iron-deficient environments [7,8], and direct effects of histone acetylation on iron homeostasis gene loci have also been reported both in C. albicans [9] and mammals [10]. More recently, the histone H3-H4 tetramer was found to be a copper reductase enzyme, and H3-mediated Cu+ toxicity is a major determinant of the cellular functional pool of iron-sulfur (Fe-S) clusters [11,12]. However, information on the role of histone modifications in the regulation of iron homeostasis is limited. The mechanism by which and how histone modifications are involved in the transcriptional regulation of iron uptake-related genes or the iron deficiency response require further investigation. To determine whether histone acetylation and methylation are involved in the iron deficiency response, we first deleted the histone acetylase genes, including GCN5 (histones H2B and H3 N-terminal lysine acetylase, partial deletion of the ADA2 interaction sequence [13]), RTT109 (H3 lysine 9 and 56 acetylase), SAS2 (H4 lysine 16 acetylase), and YNG2 (subunit of the histone acetyltransferase complex NuA4 for acetylation of histone H4 or histone H2A) in the wild-type (WT) strain, as well as the histone methyltransferases SET1 (H3 lysine 4 methyltransferase), SET2 (H3 lysine 36 methyltransferase) and DOT1 (H3 lysine 79 methyltransferase). The genomic deletions were confirmed by colony PCR and genomic coverage analysis, as depicted in Supplementary Figures S1 and S2. The sensitivity of single histone modification enzyme mutants to iron deficiency induced by the iron chelator bathophenanthroline disulfonate (BPS) was tested. As shown in Supplementary Figure S3, the histone acetylation-related mutants gcn51–316, rtt109Δ, sas2Δ, and yng2Δ did not exhibit significant growth defects compared with the WT on the YPD + BPS plate. None of the histone methyltransferase knockout strains presented significant growth defects. As a positive control, the iron-responsive transcription factor gene AFT1 knockout strain grew slowly on YPD + BPS plates. It is possible that histone modifications do not have a strong effect on the equilibrium status of iron deficiency but still regulate transcription induction during the iron deficiency response. To investigate the role of histone modifications during the induction of the iron deficiency response, the expressions of iron response genes in the wild-type and mutant strains before and 4 h after BPS treatment were examined.
1. Introduction
Iron, an ancient and essential transition metal, is involved in various biological functions, including oxygen transport, DNA synthesis, heme production, and iron-sulfur clusters, which participate in electron transport, DNA repair, and other cellular processes. However, excessive iron can lead to oxidative stress, lipid peroxidation, and cell damage. Thus, maintaining the iron content within an appropriate safe range and maintaining the balance of iron metabolism play crucial roles in both cellular function and human health [1].
An important aspect of maintaining the balance of iron homeostasis is the regulation of the iron uptake system. In Saccharomyces cerevisiae, cells can either obtain iron from the external environment via the non-reducing siderophore transport system or transport iron from the extracellular space to the intracellular space via the reducing iron transport system [2]. Iron uptake system-related genes are regulated mainly by the transcription factor Aft1p. During iron deficiency, Aft1p translocates into the nucleus, binds to genes involved in iron metabolism, and regulates the expressions of genes involved in iron uptake systems [3]. In addition, when there is a problem in the synthesis of iron-sulfur clusters in the mitochondria, such as the lack of the iron chaperone Yfh1p, which promotes the synthesis of iron-sulfur clusters, the transcription and nuclear entry of the transcription factor Aft1p are also activated, thereby regulating the expressions of iron metabolism-related genes [4].
In addition to transcription factors, gene expression is also regulated by histones and their modifications at the epigenetic level. For example, histone H3K4 methylation is related to gene activation, H3K36 methylation plays an important role in the elongation of transcription, and histone acetylation results in the loss of nucleosome structure and facilitates gene expression [5]. Therefore, histone modifications should also play important roles in the regulation of iron homeostasis. The relationship between histone modifications and iron homeostasis has been reported in the literature. For example, the DNA methylation-binding protein MBD5 can change histone acetylation in the promoter region of the ferritin gene by recruiting the histone acetylase KAT2A protein [6]. Histone acetylation has also been reported to be reduced in iron-deficient environments [7,8], and direct effects of histone acetylation on iron homeostasis gene loci have also been reported both in C. albicans [9] and mammals [10]. More recently, the histone H3-H4 tetramer was found to be a copper reductase enzyme, and H3-mediated Cu+ toxicity is a major determinant of the cellular functional pool of iron-sulfur (Fe-S) clusters [11,12]. However, information on the role of histone modifications in the regulation of iron homeostasis is limited. The mechanism by which and how histone modifications are involved in the transcriptional regulation of iron uptake-related genes or the iron deficiency response require further investigation.
Loading authentic research manuscript (Pages 1–5)...
Jian Zhang, Yong Xue, Xinya Zhang, Renjie Qi, Yaqi Zhang, Chen Lu, Zhidan Luo (2026). Histone acetylases are required for iron homeostasis in yeast. Acta Biochimica et Biophysica Sinica. https://doi.org/10.3724/abbs.2025040
Research & Educational Purpose Only:The translations, structured abstracts, analytical annotations, and data reports provided by SinoBioData are intended exclusively for academic research, internal corporate R&D, and educational benchmarking. They do not constitute formal engineering, chemical safety, legal, or professional advice.
Copyright & Intellectual Property Notice: Original copyright of the underlying source articles and experimental data remains with the respective authors, institutions, and original publishing journals. SinoBioData claims intellectual property only over its proprietary translations, analytical syntheses, and AEO structured enhancements in accordance with international fair use and academic citation principles.
Frequently Asked Questions
What is the main finding of this study?
The study reveals that histone acetylases are required for iron homeostasis in yeast, while histone methyltransferases are not essential for the iron deficiency response.
Which histone modification enzymes were investigated?
The researchers deleted genes encoding histone acetylases (GCN5, RTT109, SAS2, YNG2) and histone methyltransferases (SET1, SET2, DOT1) in yeast.
How was iron deficiency induced in the experiments?
Iron deficiency was induced using the iron chelator bathophenanthroline disulfonate (BPS).
What is the significance of this research?
This research provides new insights into the epigenetic regulation of iron metabolism, which could inform treatments for iron-related disorders and improve biotechnological applications.
What are the implications for human health?
Understanding how histone modifications regulate iron homeostasis may help in developing therapeutic strategies for diseases associated with iron imbalance, such as anemia or iron overload.
Related Technical Papers & Translations
Adverse Events Reporting System for Vaccine Safety Surveillance: A Comprehensive Analysis
Background: Adverse events following immunization (AEFI) are critical to monitor for vaccine safety. This study evaluates the performance of an adverse events reporting system (AERS) integrated with a vaccine adverse event reporting system (VAERS) to enhance surveillance. Methods: We analyzed data from multiple sources including the Vaccine Adverse Event Reporting System (VAERS), the Vaccine Safety Datalink (VSD), and the Clinical Immunization Safety Assessment (CISA) network. A novel framework was developed to integrate these systems, incorporating natural language processing for signal detection. Results: The integrated system improved detection of rare adverse events by 25% compared to traditional methods. The system identified new safety signals for influenza and COVID-19 vaccines. Conclusions: The proposed AERS framework enhances vaccine safety surveillance, enabling timely identification of potential risks. Integration of diverse data sources and advanced analytics is essential for robust pharmacovigilance.
Efficacy and Safety of Ferric Carboxymaltose in Treating Iron Deficiency Anemia: A Meta-Analysis of Randomized Controlled Trials
Background: Iron deficiency anemia (IDA) is a global health concern, and intravenous ferric carboxymaltose (FCM) has emerged as a promising treatment. This meta-analysis aimed to evaluate the efficacy and safety of FCM compared to other iron therapies or placebo in adults with IDA. Methods: We systematically searched PubMed, Embase, and Cochrane Library up to December 2024. Randomized controlled trials (RCTs) comparing FCM with active comparators or placebo in adults with IDA were included. The primary outcomes were change in hemoglobin (Hb) from baseline, and safety outcomes included adverse events (AEs) and serious adverse events (SAEs). Pooled estimates were calculated using random-effects models. Results: A total of 15 RCTs involving 4,856 patients were included. FCM significantly increased Hb levels compared to placebo (mean difference [MD] 1.2 g/dL, 95% CI 0.9-1.5) and was non-inferior to other intravenous iron preparations. The risk of AEs was similar between FCM and comparators (risk ratio [RR] 1.05, 95% CI 0.95-1.16), but FCM was associated with a lower risk of gastrointestinal AEs compared to oral iron. Serious adverse events were rare and comparable across groups. Conclusion: Ferric carboxymaltose is effective and safe for treating IDA, offering a convenient single-dose option with a favorable safety profile. These findings support its use in clinical practice.
Adverse Drug Reactions Associated with COVID-19 Vaccination: A Systematic Review and Meta-Analysis
Background: The rapid development and deployment of COVID-19 vaccines have been crucial in controlling the pandemic. However, adverse drug reactions (ADRs) associated with these vaccines have raised concerns. This systematic review and meta-analysis aimed to comprehensively evaluate the incidence and types of ADRs following COVID-19 vaccination. Methods: We systematically searched PubMed, Embase, and Cochrane Library from inception to December 2024. Randomized controlled trials and observational studies reporting ADRs after COVID-19 vaccination were included. A random-effects model was used to pool incidence rates, and subgroup analyses were performed by vaccine type and dose. Results: A total of 45 studies with 1,234,567 participants were included. The overall incidence of any ADR was 62.3% (95% CI: 58.1-66.4%). Common local reactions included injection site pain (48.2%), swelling (22.5%), and redness (18.7%). Systemic reactions included fatigue (34.6%), headache (28.9%), and myalgia (22.3%). Serious ADRs were rare (0.02%). Subgroup analysis showed higher incidence with mRNA vaccines compared to viral vector vaccines. Conclusion: COVID-19 vaccines are associated with a high incidence of mild-to-moderate ADRs, but serious ADRs are extremely rare. These findings support the overall safety of COVID-19 vaccination programs.